
Company valuation, historical trends, and peer comparisons.
According to Annexon, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 482.39M. This represents a change of -33.10% compared to the average of 721.08M of the last 4 quarters.
The mean historical Enterprise Value of Annexon, Inc. over the last ten years is 426.06M. The current 482.39M Enterprise Value has changed 13.22% with respect to the historical average. Over the past ten years (40 quarters), ANNX's Enterprise Value was at its highest in in the June 2026 quarter at 973.11M. The Enterprise Value was at its lowest in in the June 2018 quarter at 0.
Average
426.06M
Median
400.00M
Minimum
149.80M
Maximum
724.81M
Discovering the peaks and valleys of Annexon, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 356.84%
Maximum Annual Enterprise Value = 724.81M
Minimum Annual Increase = -75.43%
Minimum Annual Enterprise Value = 149.80M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 642.78M | -6.08% |
| 2024 | 684.36M | 356.84% |
| 2023 | 149.80M | -14.64% |
| 2022 | 175.50M | -56.12% |
| 2021 | 400.00M | 156.40% |
| 2020 | 156.00M | -75.43% |
| 2019 | 634.88M | 138.28% |
| 2018 | 266.44M | -63.24% |
The current Enterprise Value of Annexon, Inc. (ANNX) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
492.31M
5-year avg
410.49M
10-year avg
426.06M
Annexon, Inc.’s Enterprise Value is greater than InflaRx N.V. (78.80M), less than Immunovant, Inc. (5.27B), less than AnaptysBio, Inc. (1.57B), greater than Q32 Bio Inc. (162.49M), less than Aclaris Therapeutics, Inc. (560.80M), less than Alumis Inc. (829.56M), less than Abivax S.A. (6.43B), less than Xencor, Inc. (2.23B), greater than Prothena Corporation plc (146.44M), greater than AC Immune S.A. (148.95M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 78.80M | $251.82M | |
| 5.27B | $6.06B | |
| 1.57B | $1.43B | |
| 162.49M | $263.46M | |
| 560.80M | $579.96M | |
| 829.56M | $856.84M | |
| 6.43B | $7.59B | |
| 2.23B | $2.21B | |
| 146.44M | $427.64M | |
| 148.95M | $210.67M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Annexon, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Annexon, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Annexon, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Annexon, Inc. (ANNX)?
What is the 3-year average Enterprise Value for Annexon, Inc. (ANNX)?
What is the 5-year average Enterprise Value for Annexon, Inc. (ANNX)?
How does the current Enterprise Value for Annexon, Inc. (ANNX) compare to its historical average?